Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    N-Nitroso-N-Methyl-4-Aminobutyric Acid

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Teva recall: Tainted blood pressure drugs continue to show up in U.S. supply
    Teva recall: Tainted blood pressure drugs continue to show up in U.S. supply

    14 Jun 2019

    // Eric Palmer FIERCE PHARMA

    https://www.fiercepharma.com/manufacturing/teva-recall-tainted-blood-pressure-meds-continue-to-show-up-u-s-supply

    Eric Palmer FIERCE PHARMA
    14 Jun 2019
    Share Share
    Vivimed Life Sciences Issues Voluntary Nationwide Recall of Losartan Potassium 25 mg, 50 mg and 100 mg Tablets, USP
    Vivimed Life Sciences Issues Voluntary Nationwide Recall of Losartan Potassium 25 mg, 50 mg and 100 mg Tablets, USP

    04 May 2019

    // FDA

    https://www.pharmacompass.com/pdf/news/vivimed-life-sciences-issues-voluntary-nationwide-recall-of-losartan-potassium-25-mg-50-mg-and-100-mg-tablets-usp-1556949904.pdf

    FDA
    04 May 2019
    Share Share
    Over 100 lots of losartan tablets recalled after NMBA detected
    Over 100 lots of losartan tablets recalled after NMBA detected

    30 Apr 2019

    // Maggie Lynch IN-PHARMATECHNOLOGIST

    https://www.in-pharmatechnologist.com/Article/2019/04/29/Torrent-and-Teva-recall-losartan-tablets

    Maggie Lynch IN-PHARMATECHNOLOGIST
    30 Apr 2019
    Share Share
    EMA Urges Pioglitazone Manufacturers to Check for Nitrosamine Impurities
    EMA Urges Pioglitazone Manufacturers to Check for Nitrosamine Impurities

    26 Apr 2019

    // Zachary Brennan RAPS

    https://www.raps.org/news-and-articles/news-articles/2019/4/ema-urges-pioglitazone-manufacturers-to-check-for

    Zachary Brennan RAPS
    26 Apr 2019
    Share Share
    Legacy Pharmaceutical Packaging, Expands Voluntary Nationwide Recall of Losartan Potassium Tablets, USP, 50mg
    Legacy Pharmaceutical Packaging, Expands Voluntary Nationwide Recall of Losartan Potassium Tablets, USP, 50mg

    25 Apr 2019

    // FDA

    https://www.pharmacompass.com/pdf/news/legacy-pharmaceutical-packaging-expands-voluntary-nationwide-recall-of-losartan-potassium-tablets-usp-50mg-1556170700.pdf

    FDA
    25 Apr 2019
    Share Share
    To Prevent Losartan Shortages, FDA Allows Higher Impurity Levels
    To Prevent Losartan Shortages, FDA Allows Higher Impurity Levels

    22 Mar 2019

    // Zachary Brennan RAPS

    https://www.raps.org/news-and-articles/news-articles/2019/3/to-prevent-losartan-shortages-fda-allows-higher-i

    Zachary Brennan RAPS
    22 Mar 2019
    Share Share